Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLD + Carboplatin in Gynecologic Tumors
NCT00032162Phase 2Completed
- Sponsor
- AGO Study Group
- Start
- Aug 2001
- Primary completion
- May 2005
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin in Cervical Cancer (CC), endometrial cancer (EC), fallopian tube cancer (PFTC), ovarian cancer, sarcoma, sponsored by AGO Study Group. Started Aug 2001; status: completed.
02
Drugs
doxorubicin
03
Conditions
Cervical Cancer (CC)endometrial cancer (EC)fallopian tube cancer (PFTC)ovarian cancersarcoma
Beyond the preview
Go deeper on NCT00032162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00032162.